Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2010 2
2011 1
2012 3
2013 3
2014 1
2015 3
2016 10
2017 10
2018 21
2019 16
2020 17
2021 48
2022 53
2023 61
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

249 results

Results by year

Filters applied: . Clear all
Page 1
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.
Takhar P, Geirnaert M, Gavura S, Beca J, Mercer RE, Denburg A, Muñoz C, Tadrous M, Parmar A, Dionne F, Boehm D, Chambers C, Craig E, Trudeau M, Cheung MC, Houlihan J, McDonald V, Pechlivanoglou P, Taylor M, Wasylenko E, Wranik WD, Chan KKW. Takhar P, et al. Among authors: tadrous m. Curr Oncol. 2024 Apr 1;31(4):1876-1898. doi: 10.3390/curroncol31040141. Curr Oncol. 2024. PMID: 38668044 Free PMC article.
National trends in prescription drug expenditures and projections for 2024.
Tichy EM, Hoffman JM, Tadrous M, Rim MH, Cuellar S, Clark JS, Newell MK, Schumock GT. Tichy EM, et al. Among authors: tadrous m. Am J Health Syst Pharm. 2024 Apr 24:zxae105. doi: 10.1093/ajhp/zxae105. Online ahead of print. Am J Health Syst Pharm. 2024. PMID: 38656319
Characteristics of primary care practices by proportion of patients unvaccinated against SARS-CoV-2: a cross-sectional cohort study.
Shuldiner J, Green ME, Kiran T, Khan S, Frymire E, Moineddin R, Kerr M, Tadrous M, Nowak DA, Kwong JC, Hu J, Witteman HO, Hamilton B, Bogoch I, Marshall LJ, Ikura S, Bar-Ziv S, Kaplan D, Ivers N. Shuldiner J, et al. Among authors: tadrous m. CMAJ. 2024 Apr 7;196(13):E432-E440. doi: 10.1503/cmaj.230816. CMAJ. 2024. PMID: 38589026 Free PMC article.
Drug Shortages Prior to and During the COVID-19 Pandemic.
Callaway Kim K, Rothenberger SD, Tadrous M, Hernandez I, Gellad WF, Devine JW, Hershey TB, Maillart LM, Suda KJ. Callaway Kim K, et al. Among authors: tadrous m. JAMA Netw Open. 2024 Apr 1;7(4):e244246. doi: 10.1001/jamanetworkopen.2024.4246. JAMA Netw Open. 2024. PMID: 38578641 Free PMC article.
Navigating rare disease medications: A pharmacist's primer.
Shakeri A, Abdul Aziz Y, Tadrous M. Shakeri A, et al. Among authors: tadrous m. Can Pharm J (Ott). 2024 Jan 30;157(2):50-52. doi: 10.1177/17151635241228274. eCollection 2024 Mar-Apr. Can Pharm J (Ott). 2024. PMID: 38463174 Free PMC article. No abstract available.
249 results